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ABSTRACT: 
 Pyruvate kinase (PK), an important glycolytic enzyme that catalyzes the final step of 
glycolysis through an irreversible mechanism to produce energy for the cell, contains nine 
cysteines, some of which are highly reactive and critical for function. This research sought to 
develop a protocol to measure quantitatively the functionality of PK under different experimental 
conditions. Using a three stage, consistent procedure, it was possible to analyze the effects of 
thiol modification by Ellman’s Reagent (DTNB) and oxidation by hypochlorous acid (HOCl) on 
PK activity. Results showed that both DTNB and HOCl inhibited activity at high concentrations, 
which illustrates that some cysteines are essential for PK to catalyze its reaction. Furthermore, 
analysis of cysteine labeling with 5-iodoacetamidofluorescein on SDS-PAGE demonstrates that 
not all cysteines must be modified to see inhibitory effects. Additionally, incubation studies with 
ATP and fructose-1,6-bisphosphate, known regulators with different binding sites in PK, located 
important cysteines in the enzyme and explored their reactivity and significance. This 
characterization of the enzyme has notable implications in vivo in that PK could potentially serve 
a protective role for other cysteine-containing proteins necessary for cellular function that might 
be more sensitive to the effects of oxidative damage, such as tubulin, tau, or other glycolytic 
enzymes, accumulated damage to which could lead to neurodegenerative diseases, such as 
Alzheimer’s disease (AD).  
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PART I: INTRODUCTION: 
A. Reactivity of Cysteines and their Oxidation: 
 
 Despite their relatively low abundance when compared to other amino acids, cysteines 
(see Figure 1) are highly conserved within functional sites in proteins due to their distinctive 
chemistry (Poole, L.B., 2015). The lone pairs of electrons on the sulfur atoms make cysteines 
highly nucleophilic. Furthermore, the ionization of the thiol group (R-SH) to a thiolate ion (R-S-) 
can increase the reactivity of the cysteine and facilitate the formation of disulfide linkages, 
especially since cysteines tend to cluster, or be found together in groupings. Cysteine has a pKa 
of approximately 8.3; however, this value can change based on the specific protein environment 
in which the residue is found. The unique reactive characteristics of cysteine have led to an 
“extreme pattern of conservation at both ends of the spectrum,” meaning that cysteines can be 
“irreplaceable” and highly conserved (>90%) in certain locations but not (<10%) in others based 
on their functional importance (Poole, L.B., 2015). Conserved residues tend to be found on the 
interior of the protein since interactions with the solvent could affect reactivity and 
conformation. Lastly, cysteines are subject to oxidation by reactive oxygen and nitrogen species 
(ROS and RNS), which can drastically affect the protein’s function. 
 
Figure 1: Molecular structure of cysteine, one of the twenty naturally occurring amino acids 
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 Some degree of oxidative stress is normal in a cell, and antioxidants such as superoxide 
dismutase and glutathione ensure that ROS concentrations are maintained at non-toxic levels. 
Unfortunately, oxidants are an “unavoidable consequence of metabolism” and generally produce 
superoxide radicals (O2☻-), hydroxyl radicals, or peroxides, like hydrogen peroxide (H2O2), a 
byproduct of monooxygenases (Poole, L.B., 2015). Oxidation can lead to reversible and 
irreversible cellular damage to proteins, lipids, and DNA (Lyras, L. et al., 1997). Accumulation 
of this damage over time can lead to cancer or neurodegenerative diseases, such as Alzheimer’s 
disease (AD) and Parkinson’s disease.  
 
 When cysteines are oxidized, they have the potential to form disulfide bonds (see Figure 
2). While this could serve a post-translational regulatory purpose for some proteins, disulfide 
bonds that form where reduced thiols are required for function can have functional 
consequences. These linkages can occur between cysteines of the same protein, which could alter 
the conformation based on the distance between the residues (see Figure 2a). For example, a 
cluster of cysteines that form a disulfide bond could see minimal structural changes; however, a 
bond between two cysteines that are further away on the protein could induce a severe 
Figure 2: Possible thiol modifications in response to 
oxidation by a reactive oxygen species (ROS): 
a) disulfide bonds between cysteines within the same 
protein unit 
b) disulfide bonds between cysteines between different 
protein units 
c) formation of a sulfoxide (SOX) 
d) no effect (reduced thiols maintained) 
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conformational change that inhibits function. Additionally, cysteines between two separate 
proteins could form disulfide bonds (see Figure 2b), which could lead to a loss of function and/or 
the formation of protein aggregates, a common hallmark of neurodegeneration (Aksenov, M.Y. 
et al., 2001). Oxidized cysteines also have the potential to form sulfoxides (SOX) that have a 
high reactivity (see Figure 2c). It is important to note that oxidation does not guarantee all 
cysteines will be modified (see Figure 2d). In fact, some research has shown that a low degree of 
oxidation can have a slight activating effect on protein function (Lain, T.K., 2015). The 
functional effects of cysteine oxidation depend on the many factors, including the type of oxidant 
and its concentration, the location of the residues and the targets for disulfide linkages, and the 
extent modification has on the protein’s conformation. 
 
B. Linking Microtubules, Oxidative Damage, and Glycolytic Enzymes: 
 
There is a strong correlation between oxidative damage and neurodegeneration (Aksenov, 
M.Y. et al., 2001). Alzheimer’s disease, for example, is delineated by neurofibrillary tangles and 
amyloid plaques, both of which could be caused in part by oxidation of cysteines within the 
proteins (Dent, E.W. & Baas, P.W. 2014; Green, P.S. et al. 2004). The tangles are made from 
improperly formed networks of microtubules made of the protein tubulin. Each tubulin 
heterodimer contains an α- and β-subunit, each of which is approximately 50 kDa in size (Green, 
P.S. et al. 2004). Associations between key cysteines of tubulin molecules allow for microtubule 
elongation. Microtubule-associated proteins (MAPs), such as tau, increase the efficiency of 
microtubule formation by stabilizing the structure through electrostatic interactions (Serrano, L., 
Avila, J., & Maccioni, R.B. 1984). These cytoskeletal elements are in a flux between cycles of 
polymerization and depolymerization, which aids in their function of maintaining neuronal cell 
shape, facilitating movement of signaling molecules, and acting as a scaffold to recruit certain 
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proteins (Dent, E.W. & Baas, P.W. 2014). Thus, damage to tubulin and MAPs could have far-
reaching cellular consequences. In fact, researchers have shown in vitro that cysteine oxidation 
of tubulin and microtubule-associated protein-2 (MAP-2) by physiologically relevant oxidants 
inhibits microtubule polymerization (Landino, L.M. et al. 2002). Over time, oxidative damage to 
microtubules can amass, leading to conglomerates of the microtubule-associated protein tau, or 
neurofibrillary tangles, a common hallmark of neurodegenerative diseases. 
Furthermore, damage to tubulin can affect other cellular processes that are dependent on 
cytoskeletal networks. Due to their basic pI values, it is likely that glycolytic enzymes, among 
other molecules, interact with acidic tubulin molecules in such a way as to provide a possible 
means of regulation of the complex pathway of metabolism (Landino, L.M., Hagedorn, T., & 
Kennett, K.L., 2014). Therefore, tubulin under oxidative stress could affect cellular energetics, 
which could restrict the availability of energy-rich molecules to fuel normal cell function.  
Additionally, because glycolytic enzymes, such as glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH), lactate dehydrogenase (LDH), and pyruvate kinase (PK), are nearly 
ubiquitous and contain reduced cysteines, researchers have identified these proteins as targets for 
cysteine oxidation (Foley, T.D. et al. 2014). The effects of oxidative damage to these enzymes 
are not well characterized, however. It is likely that loss of function could occur, but researchers 
have yet to determine the extent and at what concentration of oxidant. Glycolytic enzymes may 
play additional roles in cellular processes, such as the link between pyruvate kinase and cell 
growth and cancer and immunity (Gau, X., et al., 2013; Uzan, J, et al., 2011). Therefore, damage 
to these enzymes could have consequences beyond inhibited cellular energetics. Taken together, 
glycolytic enzymes under oxidative stress are an interesting target of research due to the potential 
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for both loss of regulation from microtubule destabilization and oxidative inhibition of enzymatic 
function.   
 
C. Pyruvate Kinase: 
Pyruvate kinase (PK) is a key enzyme in glycolysis, which catalyzes the conversion of 
phosphoenolpyruvate (PEP) and ADP to pyruvate and ATP illustrated in Figure 3. Due to the 
highly exergonic nature of this reaction, PK mediates an irreversible step, making the enzyme an 
important target for metabolic regulation. Producing 2 moles of ATP and 2 moles of pyruvate per 
1 mole of glucose, PK paves the way for further metabolic processes and energy harvesting, both 
aerobically and anaerobically. The highly specific structure of pyruvate kinase amplifies small 
molecular changes, which has profound effects on the enzyme’s function. PK has two main 
binding sites, an active site and a regulatory site, each of which contain important cysteines. The 
location of these cysteines and their interactions with monovalent and divalent metal cations 
affect the extent to which oxidative damage occurs for rabbit muscle PK. 
 
Figure 3: The reaction catalyzed by pyruvate kinase 
As with all proteins, pyruvate kinase’s structure is essential for function. The enzyme is a 
tetramer weighing approximately 200 kDa  (Lee, J.C., & Herman, P., 2010; Valentini, G. et al., 
2002). Each of the four identical subunits (shown in Figure 4) has approximately 530 residues 
that form three domains: “a small N-terminal helical domain, a β-α barrel domain surrounding a 
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β barrel domain, and a three-layer α-β-α sandwich domain” (Lee, J.C., & Herman, P., 2010; 
UCSD Signaling Gateway, 2014; Valentini, G. et al., 2002). Each domain has an activator-
binding site, corresponding to the reactants, PEP and ADP, and the allosteric regulator, fructose-
1,6-bisphosphate. (Valentini, G. et al., 2002). Allosteric regulation can activate or inhibit one of 
the binding sites, which is located in a cleft between the two β barrel domains, by rotating those 
domains. Because of the effects of allosteric molecules, the four clefts are important regulatory 
sites for the enzyme (UCSD Signaling Gateway, 2014; Valentini, G. et al., 2002). PK is inhibited 
by acetylCoA, alanine, or ATP and activated by fructose-1,6-bisphophate (FBP) or AMP. 
Covalent modification of the protein due to insulin, an activator, or glucagon, an inhibitor, can 
affect the enzymatic rate. Changes in metabolic efficiency beyond general regulation have been 
linked to cell growth, cancers, and immunity. 
Most research involving pyruvate kinase involves rabbit PK. Rabbits have four forms of 
PK: L, found in the liver; R, in red blood cells; M1, in muscle, heart, and brain tissue; and M2, in 
early fetal tissue (UCSD Signaling Gateway, 2014). M1 and M2 stem from the same genetic 
coding region but differ because of alternative splicing of mRNA transcript (Valentini, G. et al., 
2002). Although the isoforms have the same function for energy harvesting and pyruvate 
production, each differs slightly in primary structure, which translates into larger differences in 
regulation for the enzyme (Table 1). Because PK-L is involved in maintaining necessary glucose 
levels, it is the most sensitive to allosteric regulation from fructose-1,6-bisphosphate, ATP, 
alanine, as well as hormonal regulation from insulin and glucagon. On the other hand, PK-M1 is 
only inhibited by ATP because brain and muscle tissue need a constant supply of glucose to 
function properly. Although, research has shown that phenylalanine can significantly reduce the 
enzymatic capabilities of the M1 isoform and Zn2+ can reduce that of both the M1 and M2 
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isoforms (Li, F., Yu, T., Jiang, H., & Yu, S., 2013; Tamaki, N., Ikeda, T., Kimura, K., & 
Morioka, S., 1981). The reduction in sensitivity to allosteric molecules in PK-M1 and PK-M2 
causes less fluctuating glucose levels than PK-L (UCSD Signaling Gateway, 2014). The different 
isoforms in rabbit PK give a greater range of sensitivity and specificity to PK experimentation. 
Isoform Activators Inhibitors 
PK-L Fructose-1,6-bisphosphate (FBP), 
AMP 
ATP, acetylcoA, alanine 
PK-R Fructose-1,6-bisphosphate (FBP), 
AMP 
ATP, acetylcoA, alanine 
PK-M1 Fructose-1,6-bisphosphate (FBP), 
AMP 
ATP; phenylalanine; Zn2+ 
PK-M2 Fructose-1,6-bisphosphate (FBP), 
AMP 
ATP; Zn2+ 
Table 1: Differences in regulation for the four isoforms of pyruvate kinase 
 
D. Potential Protective Effects of Cations Against Oxidative Damage to Pyruvate Kinase: 
The cations K+ and Mg2+ are necessary for pyruvate kinase activity and may have 
protective effects. The activator-binding site in each subunit interacts with a catalytic center for 
which both magnesium and potassium ions are necessary (Valentini, G. et al., 2002). It has been 
proposed that the cations are part of the PEP binding site of muscle PK (Brown, C.E., Taylor, 
J.M., & Chan, L., 1985). Further research supported this idea after finding four total binding sites 
per PK for monovalent metal cations, divalent metal cations, and PEP (Flashner, M., Hollenberg, 
P.F., & Coon, M.J., 1972). Potassium ions increase the binding affinity for PEP to increase the 
maximum velocity of the reaction, and magnesium ions counteract the negative charge of ADP 
and stabilize the enol-form of pyruvate in the intermediate and transition states (Orla-Hernandez, 
J. et al., 2005). Moreover, PK seems to have a particular defense mechanism against low levels 
of oxidative stress such that the catalytic ability of reactive cysteines is maintained (Lane, T.K., 
2015). When present together with an oxidant, it is likely that Mg2+ and K+ protect PK to 
maintain activity (Flashner, M., Hollenberg, P.F., & Coon, M.J., 1972). Therefore, it appears that 
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the ions involved in the PEP binding site act as the defense mechanism against oxidative damage 
in addition to maximizing enzymatic efficiency. 
 
E. Cysteines in Pyruvate Kinase: 
 
Figure 4: The cysteines in a pyruvate kinase monomer oriented alongside the functional tetramer 
 
Pyruvate kinase has many important thiol groups, which makes the enzyme an 
intracellular target for oxidative damage. Each of the four subunits has nine cysteine residues as 
illustrated in Figure 4 (Flashner, M., Hollenberg, P.F., & Coon, M.J., 1972; Rafter, G.W., & 
Blair, J.B., 1987). One of these cysteines per subunit is minimally reactive but necessary for 
catalytic function; another is highly reactive but not essential for enzymatic activity. The 
minimally reactive cysteines are necessary for catalytic function because these cysteines activate 
and stabilize PK at low pH or in the presence of PEP and metal cations (Flashner, M., 
Hollenberg, P.F., & Coon, M.J., 1972). The cations Mg2+ and K+ likely shield these cysteines to 
prevent loss of function (Flashner, M., Hollenberg, P.F., & Coon, M.J., 1972).  Because cations 
are only active in the PEP binding site, it is likely that the PEP binding site of each subunit 
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contains the less reactive but necessary cysteines (Brown, C.E., Taylor, J.M., & Chan, L., 1985; 
Flashner, M., Hollenberg, P.F., & Coon, M.J., 1972).  Furthermore, because the PEP binding site 
is the primary active site of the protein and necessary for all PK isoforms, the cysteine in this 
location is highly conserved, a common result of selective pressure for irreplaceable cysteines in 
a protein’s interior (Poole, L.B., 2015). Based on a 2011 study in which PK was mutated and 
cysteine residues were replaced with serines, it is possible that the minimally reactive but 
necessary cysteine in each subunit is Cys 357, a residue located in the β-barrel that “includes 
residues essential for catalytic activity” and “primarily accounts for ROS-induced inactivation” 
(Anastasious, D., et al., 2011). The quaternary structure of PK minimizes access to Cys 357, 
which could account for the low reactivity of these residues (Anastasious, D., et al., 2011). Thiol 
reagents, particularly Ellman’s Reagent (5,5-dithio-bis-[2-nitrobenzoic acid]), a thiol-specific 
reagent, and GSSG, an oxidized form of glutathione that serves as an intracellular antioxidant, 
react with cysteines to change the affinity for PEP but not fructose-1,6-bisphosphate (Rafter, 
G.W., & Blair, J.B., 1987), which would indicate that these agents inhibit PK’s ability to 
catalyze a reaction. These oxidants could affect the less reactive but catalytically necessary 
cysteines in PK. If an ROS is present, either after the reaction occurs or as part of the incubation 
mixture, it is likely that fructose-1,6-bisphosphate can bind in the allosteric site and counteract 
loss of function by preventing conformational changes to the β-barrel that render the enzyme 
unable to catalyze reactions (Anastasious, D., et al., 2011; Rafter, G.W., & Blair, J.B., 1987). 
Oxidative damage to these minimally reactive cysteines impedes catalytic function. 
The highly reactive cysteines are more accessible to oxidants. Based on the same 
previously referenced 2011 study, it is possible that these highly reactive cysteines are either 
Cys30 or Cys422, both of which are highly accessible by the solvent (Anastasious, D., et al., 
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2011). There is most likely a cysteine in the fructose-1,6-bisphosphate binding site that is not 
shielded by the cations necessary for PK’s function (Brown, C.E., Taylor, J.M., & Chan, L., 
1985). While the cysteine in this binding site is found in PK isoforms sensitive to regulation by 
fructose-1,6-bisphosphate, it is not conserved to the extent of the cysteine in the PEP binding 
site. Because the cysteines in the fructose-1,6-bisphosphate binding site are accessible and 
unprotected, they are likely the more reactive but non-essential cysteines. The increased 
reactivity is likely due to the more exposed location of the cysteine in the fructose-1,6-
bisphosphate regulatory site, which, combined with the fact that the sequence tends to be less 
conserved than that of the PEP binding site, would make sense for the cysteine in the regulatory 
site to have decreased selective pressure since the residue is not critical to enzymatic function 
(Poole, L.B., 2015). This idea is further supported by research illustrating that thiol reagents do 
not affect the fructose-1,6-bisphosphate affinity (Rafter, G.W., & Blair, J.B., 1987). Although the 
cysteines are modified, there is only an alteration of the enzyme’s kinetic properties; the catalytic 
ability of the enzyme is not impaired (Rafter, G.W., & Blair, J.B., 1987). Thus, the fructose-1,6-
bisphosphate binding site likely has the non-essential cysteine. Oxidation of these highly reactive 
cysteine residues does not affect PK’s function.  
When oxidized, the cysteines in PK are likely to form disulfide bridges, and the resulting 
change in structure affects the enzyme’s function. In order to successfully modify the 
catalytically essential cysteines in the PEP binding site, ions cannot be present in the buffer. The 
potential protective effects could shield the cysteines from oxidative damage, which would lead 
to unreliable results on enzyme catalysis. It is possible that the oxidation of PK’s cysteines could 
be reversed via reduction processes, which could further restore the enzyme’s function. 
Preliminary studies seem to illustrate that PK’s activity can be modulated by cellular redox 
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conditions; however, the oxidative damage to the enzyme was most likely minimal during the 
experiments because PK was reacted with oxidants in the presence of cations, which could 
confound the results (Lain, T.K., 2015). Further experiments will be necessary to understand the 
full extent of the enzyme’s self-regulation and the effects of this capability on other molecules in 
the cell. If PK is able to prevent oxidative damage by shielding itself through interactions with 
cations, it may be possible that the enzyme can buffer oxidative damage to other intracellularly 
targeted molecules. Damage to these molecules, such as glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) and tubulin, could have long-lasting cellular effects including 
neurodegenerative diseases like Alzheimer’s and Parkinson’s diseases (Landino, L.M., 
Hagedorn, T., & Kennett, K.L., 2014). Based on the pI values of PK, GAPDH, and tubulin, it is 
likely that these molecules interact electrostatically, which further illustrates the importance of 
PK’s potential ability to modulate oxidative environments (Landino, L.M., Hagedorn, T., & 
Kennett, K.L., 2014). Therefore, research on pyruvate kinase and oxidative stress could have 
important results for understanding cellular regulation. 
 
F. Goals of this Research: 
 Taken altogether, pyruvate kinase is an important enzyme in metabolism that warrants 
further study. Because glycolytic enzymes are ubiquitous in vivo and requires reduced cysteines 
for proper function, thiol modification in response to oxidative stress could have dramatic effects 
on enzymatic activity. Therefore, it is possible for extensive oxidative damage over time to 
decrease energy metabolism, induce protein aggregation, and have other negative intracellular 
consequences associated with neurodegenerative diseases, such as Alzheimer’s disease and 
Parkinson’s disease. 
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The primary aim of this thesis was to develop a functional protocol for an assay that 
would give a reliable measure of PK activity for the purposes of analyzing the effects of 
oxidation. Drawing from assays used by a previous student in the laboratory of Dr. Landino, this 
protocol sought to control for the potential protective effects of the monovalent and divalent 
cations, the variability from small sample preparations, and the kinetic rate of lactate 
dehydrogenase during the coupled assay. By having an established methodology in place, it was 
possible to investigate PK activity in response to various modifications. 
 Once the protocol was shown to be consistent, the goals of this thesis expanded to gain a 
larger understanding of PK in response to oxidative stress. To what extent does oxidation target 
cysteines? How does PK activity after treatment with Ellman’s reagent, a thiol-specific reagent, 
compare to that after treatment with hypochlorous acid (HOCl), a non-specific oxidant? Do ions 
protect PK from oxidation, and, if so, to what extent? How does the presence of ligands, such as 
adenosine triphosphate and fructose-1,6-bisphosphate, affect oxidative damage if present 
throughout oxidation reactions? Do these molecules give insight into the location of key 
cysteines in PK?  
 Because of the association between glycolytic enzymes, microtubules, and oxidative 
stress, understanding how oxidation affects pyruvate kinase could help researchers better 
understand early cellular changes in the complex progression of neurodegenerative diseases. As 
oxidized PK has a reduction in energy metabolism, potential conformational changes from 
disulfide linkages could alter interactions with tubulin in the microtubule network that might 
accelerate the formation of tau conglomerates, called neurofibrillary tangles, a characteristic of 
Alzheimer’s disease. Therefore, while the goals of this research are narrow in scope, the results 
could help add to the larger picture of neurodegeneration.    
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PART II: METHODS AND MATERIALS: 
 
A. Materials:  
Pyruvate kinase from rabbit muscle (PK-M2), HOCl, 5-(Iodoacetamido)fluorescein (IAF), 
disodium salt of ATP, trisodium salt of PEP, and 5,5′-Dithiobis(2-nitrobenzoic acid) (DTNB) 
were obtained from Sigma-Aldrich.  Guanidine hydrochloride, ammonium persulfate, and 
TEMED were purchased from Fisher Scientific.  FBP was purchased from Alfa Aesar.  Ethyl 
alcohol was obtained from Pharmco-Aaper.   
 
B. Pyruvate Kinase Purification:  
The commercially available rabbit muscle PKM2 samples in the laboratory came in two 
varieties: type II and type III. Very little literature could be found on the differences in these 
products, but activity assays determined the enzymes to have parallel activity. It is likely that the 
only difference in these products is the preparation method. Type II is found in an ammonium 
sulfate solution, and type III is a solid lyophilized powder. To control for possible air oxidation 
of PK and to ensure all of the enzyme in the sample was fully reduced, PK was treated with DTT 
to reduce any disulfides present in the commercial products. Then, to remove the DTT and 
collect the reduced enzyme, samples were run on a desalting column. Using absorbance 
measurements (E!"#!% =5.4), the final concentrations of the reduced enzymes were calculated as 1.3 
mg/mL and 1.64 mg/mL for PK type II and type III, respectively. 
 
C. Coupled Lactate Dehydrogenase Activity Assays: 
 This assay design is broken into three stages to streamline the process and to reduce error 
as illustrated in Figure 5 below. A major portion of this project was to develop a working assay 
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to measure pyruvate kinase activity through nicotinamide adenine dinucleotide (NADH) 
absorbance, and more complete details on this process and each stage can be found in the “Data 
and Results” section. 
 
Figure 5: Graphical representation of the stepwise approach to the coupled LDH activity assay 
 
 The first stage of the assay oxidized pyruvate kinase in 0.1 mM phosphate buffer pH 7.4 
to give a final solution volume of 15 µL. PK was added to give a final concentration of 0.43 
mg/mL or 7.5 µM in solution. With each subunit having nine cysteines, the maximum 
concentration of thiols available for modification would be 67.9 µM, but it is unlikely that all 
could be reached because many are found in the interior of the protein. Reactions proceeded 
following the outlined procedure in Table 2. After the addition of the oxidant, the reaction was 
preceded to react for 10 minutes at room temperature. Modifiers, including hypochlorous acid 
and Ellman’s Reagent (DTNB) were added to give a final concentration of 0, 25, 50, 100, or 250 
µM. The concentrations were chosen because they gave simple factors for the ratio of cysteines 
to oxidant shown in Table 2. As the ratio shifts in favor of the oxidant, it becomes more likely 
that an oxidant could come in contact with a thiol and modify the residue.  
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Concentration of 
Oxidant 
0.1 mM PB 
7.4 
1.3 mg/mL 
PK 
HOCl Cys:Oxidant 
Control 10 µL 5 µL 0 µL -- 
25 µM HOCl final 6.25 µL 5 µL 3.75 µL 100 
µM 
1:10 
50 µM HOCl final 8.5 µL 5 µL 1.5 µL 500 µM 1:20 
100 µM HOCl final 7 µL 5 µL 3 µL 500 µM 1:40 
250 µM HOCl final 5 µL 5 µL 5 µL 750 µM 1:100 
 Table 2: Oxidation conditions for various samples of hypochlorous acid 
Next, the volume of the Stage 1 solution was added to 240 µL of an equimolar Stage 2 
solution containing 3 mM phosphoenolpyruvate (PEP) and adenosine diphosphate (ADP). This 
reaction proceeded for 5 minutes at room temperature. At the end of the 5 minutes, 15 µL ZnCl2 
was added to inhibit PK and stop the reaction. This ensured no further reaction products formed. 
 Lastly, the Stage 2 solution was divided into 50 µL portions in each of 5 wells of a 96-
well plate. Each well also contained 150 µL of the Stage 3 solution: final concentrations of 0.5 
mM nicotinamide adenine dinucleotide (NADH) and 0.0055 µg/µL lactate dehydrogenase in 
STris buffer, 50 mM Tris buffer with final concentrations of 100 mM KCl and 10 mM MgSO4. 
To reduce error, the Stage 3 solution was mixed in sufficient volume for 10 wells then divided. 
The assay conditions for each individual well are summarized in Table 3 below. The plate was 
read both before and after the addition of the Stage 2 solution on the BioTek ELx808 absorbance 
plate reader in order to calculate the percent change in NADH absorbance at 340 nm. Data for 
each reaction condition was collected from a minimum of three runs with a run consisting of 5 
wells of the 96-well plate.  
Stage  Reagent Blank Control Sample Final Concentration 
1 PK Solution  0 µL 0 µL 3 µL 0.0075 mM (7.5 µM) 
2 3 mM ADP/PEP 0 µL 0 µL 44 µL 0.66 mM 
2 20 mM Zn2+ 0 µL 0 µL 3 µL 0.03 mM 
3 1:5 LDH 0 µL 0 µL 2 µL 0.039 µM 
3 10 mM NADH 0 µL 10 µL 10 µL 0.5 mM 
3 STris Buffer 200 µL 190 µL 138 µL --------- 
Table 3: Assay conditions for each 200 µL well in a 96-well plate 
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D. Visualization of IAF Tagging by SDS-PAGE: 
In order to visualize how oxidation affects the cysteines in pyruvate kinase, samples were 
tagged with 5-iodoacetamidofluorescein, a fluorescent yellow tag that binds to reduced cysteines. 
Samples were prepared in the same 15 µL volumes as those used for the coupled lactate 
dehydrogenase activity assays. Next, 0.9 µL 25 mM IAF was added to each sample (for a final 
concentration of 1.4 mM IAF) and incubated for 30 minutes to allow the reaction to occur. After 
incubation, 16 µL of SB (+) was added to each sample, and the total volume was loaded onto a 
7.5% SDS-polyacrylamide gel. The gel ran for 90 minutes at 90 V before visualization with the 
BIO-RAD ChemiDoc XRS+ imaging system. 
PART III: DATA AND DISCUSSION: 
A. Lactate Dehydrogenase Coupled Assay Development: 
The efficiency of the reaction catalyzed by PK cannot be measured directly, so this 
research relied on a pyruvate kinase-lactate dehydrogenase (LDH) coupled enzyme assay in 
order to measure PK activity quantitatively. PK converts adenosine diphosphate (ADP) and 
phosphoenolpyruvate (PEP) into pyruvate and adenosine triphosphate (ATP). The pyruvate 
produced from the reaction becomes the substrate for lactate dehydrogenase that reduces 
pyruvate into lactate while oxidizing nicotinamide adenine dinucleotide (NADH). Because 
NADH absorbs at 340 nm and the oxidized NAD+ does not, measuring the percent change in 
absorbance at 340 nm gives a quantitative measure of the efficiency of the PK under different 
physiological conditions. While previous studies have measured the kinetic rate of the NADH 
oxidation reaction to determine the effects of oxidation, this form of data collection could be 
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confounded based on the LDH reaction rate in the coupling. Measuring the percent change in 
NADH absorbance from the initial and final absorbance readings allowed for a control of the 
LDH reaction since kinetic rates for the two enzymes were no longer necessary. Although the 
reactions are coupled, treating each reaction as an independent step streamlined the process and 
decreased the chance for error. Solutions were made in larger volumes then distributed 
throughout the wells in a 96-well plate, which reduced the chance for error. The assays were 
divided into three sequential stages schematically illustrated in Figure 6: 1) PK modification, 2) 
PK catalysis, and 3) LDH catalysis.  
 
Figure 6: Outline of developed protocol for pyruvate kinase activity assay 
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Stage 1: 
First, PK must be reacted with a physiologically relevant oxidant in 0.1 M phosphate 
buffer at pH 7.4 lacking ions. Stage 1 occurred at room temperature for 10 minutes at a final 
volume of 15 µL. Because phosphate is fully oxidized, the oxidant could only react with the 
enzyme and not with the buffer. Hypochlorous acid was added under varying final 
concentrations (0-250 µM) to analyze the extent of general oxidative damage on the protein. For 
comparison, pyruvate kinase was treated with Ellman's Reagent (5,5'-dithio-bis-[2-nitrobenzoic 
acid]), a cysteine-specific reagent, to observe the changes in activity against the non-specific 
interactions of hypochlorous acid. Based on a previous student’s research in the lab, hydrogen 
peroxide, a common antioxidant under physiological conditions, did not oxidize PK to enough of 
a degree to warrant further focus. For this reason, hydrogen peroxide was not used as an oxidant 
in this project. Later in the research, various chemicals that act as reducing agents were added to 
the oxidized PK in order to determine if oxidative damage could be reversed under appropriate 
conditions.  
Researchers have debated the role ions (Mg2+ and K+) play in oxidative stress. While 
some research indicates that the ions serve as a protective mechanism for cysteines critical for 
PK function and serve as a defense against oxidative stress, other research seems to indicate that 
ions hold the protein in a conformation that makes cysteines more accessible for oxidants to 
react. Because more research seems to indicate protective effects of ions, Stage 1 of the assay 
excluded Mg2+ and K+ but also examined the effects of the ions in further experiments. Reacting 
PK with oxidants without ions was thought to give a better sense of the capabilities of the 
oxidants. 
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Stage 2: 
The next stage of the assay included the PK reaction. In order to produce pyruvate, the 15 
µL of the modified PK from Stage 1 was added to 240 µL of a 1.6 mM 1:1 solution of PEP:ADP 
in 50 mM Tris buffer with final concentrations of 100 mM KCl and 10 mM MgSO4. The buffer 
with ions, termed “STris,” was made from a 1:1 dilution of 0.1 M Tris buffer in deionized water 
with salts added to achieve the stated final concentrations. STris follows the ion concentration of 
other prominent research with PK and is necessary because the enzyme requires these ions in 
order to produce pyruvate. Experimentation illustrated that these ion concentrations were 
sufficient for PK activity and did not limit functionality of PK. Initial testing was focused on 
determining controls for reduced conditions:  1) the concentration of PK needed for the reaction 
to occur, 2) the time the reaction should run before PK has produced all of the pyruvate it can 
with the given reagent concentrations, and 3) the method of inhibition to provide a mechanism of 
control.   
When determining the concentration of PK to use in each sample, the main consideration 
was the final absorbance at 340 nm. An absorbance measurement below 0.1 has questionable 
reliability due to the detection limits of the spectrophotometer. For that reason, the concentration 
of PK for the unmodified enzymatic control needed to reduce the NADH absorbance to about 
0.100 but not below – approximately a 90% decrease. A final concentration of 0.0065 µg/µL PK 
in the 200 µL well solution provided the required percent change.  
A system of trial and error was necessary with regard to the time for the reaction to take 
place. Using an estimated five-minute timeframe, the control reaction saw a 90% decrease in 
NADH absorbance, which indicated that the reaction was able to produce enough pyruvate for 
the LDH-coupled reaction to occur within the desired range.  
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At the end of the five-minute reaction period, there needed to be a mechanism to inhibit 
further PK activity to control for the time PK is able to react with its substrates. This ensured that 
the reaction was not continuing to produce pyruvate while the LDH assay and data collection 
period was underway, which could confound the results by increasing the amount of NADH 
oxidation possible due to a longer time to react. Zinc ions have been shown to inhibit this 
isoform (M2) of PK by competing with Mg2+ in the active site. While the literature suggests that 
a final zinc concentration of 0.1 mM in each 200 µL well sample of the 96-well plate would be 
sufficient to inhibit PK activity, this research indicates that 0.1 mM Zn2+ only inhibited activity 
by 19% of the uninhibited control (Tamaki, N., Ikeda, T., Kimura, K., & Morioka, S., 1981). At 
this concentration, PK activity was decreased to approximately 80% of the control as 
summarized in Figure 7. Although lowered from the initial 10 mM MgSO4 previously contained 
in STris from a previous student’s research on the topic, it is likely that the 2.5 mM magnesium 
ion concentrations used in this STris buffer were high enough in outcompete the zinc ions in the 
ADP/ATP binding site in order to maintain enzymatic activity. 2.5 mM was chosen after 
examining another paper that used PK-LDH coupled assays with great success at this 
concentration of ion (Tamaki, N., Ikeda, T., Kimura, K., & Morioka, S., 1981). For this reason, 
additional Zn2+ was added to give a final concentration of 0.3 mM in the 200 µL well volume (or 
1.1 mM in the reaction mixture with only ADP, PEP, and PK before adding the solution to the 
LDH-coupled reaction mixture). Experimentation showed that a final concentration of 0.3 mM 
ZnCl2 decreased activity by 44% and decreased the percent change in NADH absorbance from 
92% (0 mM Zn2+) to 48% - approximately 52% of the control. From the 20 mM ZnCl2 stock 
solution, a final zinc ion concentration of 0.1 mM required 1 µL per 200 µL well while that of 
0.3 mM required 3 µL per 200 µL well. Perhaps the concentration of ZnCl2 could have been 
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increased in an effort to obtain near complete inhibition of PK; however, the degree of inhibition 
had to be weighed against the volume added since it diluted the pyruvate produced necessary for 
the LDH coupled assay in Stage 3. Further, data over the length of the LDH kinetics run showed 
that 0.3 mM Zn Cl2 inhibited sufficiently to maintain a consistent final NADH absorbance for 
each reaction. Therefore, it was decided that 0.3 mM ZnCl2 met the needs 15 µL of 20 mM Zn2+ 
was added to each 255 µL Stage 2 solution after the 5 minute reaction time before distributing 
the solution into the wells. Once the final concentration of pyruvate has been reached, the assay 
can proceed to Stage 3. 
 
Figure 7: Inhibition of pyruvate kinase activity at various concentrations of Zn2+ 
Stage 3: 
The final stage for the assay revolved around the LDH-catalyzed reaction. In order to 
analyze the effects of PK modification on its activity, there needed to be a way to analyze the 
change in concentration of NADH as the coupled reactant is oxidized to NAD+ by LDH. From 
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Stage 2, the maximum concentration of pyruvate that could have been produced from the 
reagents was 1.6 mM. Adding 50 µL of this solution to sample well with 150 µL of a pre-mixed 
solution of LDH, NADH, and STris distributed throughout the sample wells gave a maximum 
final concentration of pyruvate of 0.4 mM. In order for the effects to be attributed to PK 
modification rather than mere NADH oxidation by exposure to air, the concentration of pyruvate 
must be less than that of NADH in the final 200 µL volume. An initial NADH concentration of 
0.5 mM gave a starting absorbance (A340i) between 1.5 and 2. It is worth mentioning that the 
sample wells did not contain the full 200 µL volume when measuring the initial absorbance 
because the 50 µL of the PEP/ADP/PK solution had not been added. Controlling for this volume, 
an increase of 50 µL from STris increased the absorbance by about 5%. Therefore, a decrease in 
NADH absorbance is not due simply to the change in volume. Furthermore, this increase is 
unlikely to cause a significant change in the quantitative data because it modified percent change 
in absorbance by less than 1%. By measuring the absorbance of NADH, it is possible to 
determine the amount of pyruvate produced by modified PK compared to the reduced standard. 
Similarly to the first step of the coupled reaction, initial experimentation determined the controls: 
1) the concentration of LDH necessary for conversion of pyruvate to lactate and 2) the time the 
reaction should run before all of the NADH has been oxidized.  
For the reaction to be successful, LDH needed to be added in excess such that the 
resulting concentration of pyruvate is the limiting factor rather than the enzymatic rate. Initially, 
each 200 µL well solution contained 0.00275 µg/µL LDH. The percent decrease in NADH 
absorbance for the unmodified PK control was approximately 40%. Since the ideal change was 
closer to 90%, the LDH concentration in each well was doubled to 0.0055 µg/µL. Results of the 
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updated protocol matched the intended values, which illustrated the necessity of altering the 
protein amount for catalysis.   
Based on the results of absorbance measurements over the span of an hour for the 
unmodified PK control, all of the NADH is oxidized within seven minutes of adding the Stage 2 
solution, which is why the plate needs to be analyzed by the absorbance reader within two 
minutes of the first sample being added to the well in order to have comparable results across 
samples at the end of the five minute LDH-coupled activity experiment. This limitation restricted 
the number of samples per run to two, each of which provided enough solution for five wells.  
 
B. Modification by Ellman’s Reagent: 
To determine the extent to which an oxidant in solution could access the cysteines in 
pyruvate kinase, Ellman’s Reagent (5,5'-dithio-bis-[2-nitrobenzoic acid]), or DNTB, was used as 
a control. DTNB is a thiol-specific agent due to its reactive thiol group that can undergo thiol-
disulfide exchange to modify its target. In this case, DTNB modified cysteines and likely 
induced some disulfide linkages between cysteines on the same subunit or on different subunits, 
which has the potential to cause conformational change that affects enzymatic activity. Through 
these modifications of the cysteine residues, it was possible to determine that some of the nine 
cysteines in each PK subunit are accessible for modification, as well as the effect of these 
modifications on PK function.  Additionally, the effects of cations present in solution during 
modification was examined to see if the ions protect the enzyme from modification as potentially 
indicated in the research (Flashner, M., Hollenberg, P.F., & Coon, M.J., 1972). 
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Visualization with IAF Labeling: 
 In an effort to determine the extent to which cysteines are accessible for modification, PK 
samples were incubated with different final concentrations of DTNB (0, 440, 590, and 880 µM) 
in the Stage 1 modification step for 10 minutes at room temperature. After this reaction window, 
the samples were tagged with IAF and visualized on the SDS-PAGE shown in Figure 8. As the 
concentration of DTNB increased, the extent of IAF labeling decreased. This is logical because 
thiol-disulfide exchange between DTNB and the thiol group of PK’s cysteines likely formed 
disulfide bonds between residues that decreased the number of free thiols available for the 
fluorescent tag. These results indicate that cysteines can be modified, but further analysis was 
necessary to understand the effects of these modifications on enzymatic activity.   
 
Figure 8: Visualization of pyruvate kinase oxidation by varying final concentrations of DTNB with IAF 
labeling 
Lane A: 0 µM  Lane B: 880 µM  Lane C: 590 µM  Lane D: 440 µM 
Figure courtesy of Duff, M.C. & Landino, L.M. (2017). 
 
Effects on Enzymatic Activity: 
 In order to show that modification by DTNB affected PK activity, samples with a final 
concentration of 0 and 200 µM DTNB in phosphate buffer without ions were analyzed with 
activity assays as shown in Figure 9. The control (0 µM DTNB) saw a percent decrease in 
NADH absorbance at 340 nm of 92% with a spread of 0%. At 200 µM DTNB, activity was 
impacted such that the percent change in absorbance was only a loss of 69% ranging from a 
decrease of 64-74%. At least some of the cysteines, then, are necessary for proper enzymatic 
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function. This information was necessary to understand the effects an oxidant could have on the 
enzyme and provided an important control for treatment with HOCl. 
 
Ion Effects: 
Since research seemed to indicate the possibility of cations (Mg2+ and K+) serving as a 
defense mechanism against damage to the protein, exposure to DNTB in the presence of these 
ions could decrease the extent of thiol-disulfide exchange to reduce the loss of function 
experienced by the ion-free 200 µM DTNB sample (Flashner, M., Hollenberg, P.F., & Coon, 
M.J., 1972). Instead of the 100 mM phosphate buffer pH 7.4 used in the Stage 1 modification, 
samples were reacted in SPBS (50 mM phosphate buffer pH 7.4 with 100 mM KCl and 10 mM 
MgSO4). Activity assay controls did not show a difference in enzymatic function between the 
different buffers.  
Again, the PK samples were run with 0 and 200 µM DTNB, and the results are presented 
in Figure 9 below. Interestingly, the presence of ions in solution actually increased the loss of 
function to the enzyme. No protective effects were observed with modification by DTNB. As 
compared to the PBS control at the same level of modification by DTNB that saw a percent 
decrease in absorbance at 340 nm of 69%, the SPBS samples decreased absorbance by 51% over 
a span of 42-60%. After additional research, it appears that divalent metal ions (i.e. Mg2+) 
increased DTNB modification of thiol groups in rabbit muscle PK-M2 by inducing different 
conformational changes that allow for a greater extent of thiol-disulfide exchange that mimics 
allosteric conformational changes (Kwan, C.Y. & Davis, R.C. 1981). Therefore, the ions in 
solution actually serve to increase damage from DTNB modification rather than to protect as is 
the case in literature with exposure to an ROS. 
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Figure 9: Changes in pyruvate kinase activity at various final concentrations of DTNB in the presence or 
absence of cations 
PBS: 100 mM pH 7.4 SPBS: 50 mM PB pH 7.4 50 mM PB pH 7.4 w/ 100 mM KCl + 10 mM MgSO4 
 
C. Oxidation by Hypochlorous Acid: 
While DTNB is a great control to show that oxidation of pyruvate kinase’s cysteines 
inhibits activity, oxidation in physiological systems is likely to be less specific and have the 
potential to affect activity to a larger extent because of the broader range of possible targets. In 
order to replicate cellular oxidative conditions, hypochlorous acid (HOCl) was chosen as a 
physiologically relevant oxidant for studies on PK activity. In addition to HOCl produced in 
other contexts, a 2004 paper reported uncharacteristically high levels of HOCl generated from 
increased expression of the enzyme myeloperoxidase (MPO) in neurons in the brain of patients 
with Alzheimer’s disease (Green, P.S. et al. 2004). In an effort to understand how exposure to 
HOCl affects PK function, enzyme samples with exposure to increasing concentrations of the 
oxidant were visualized with IAF labeling and analyzed with an activity assay (see Table 2 for 
experimental conditions). Similarly to studies with DTNB, the effects of cations present in 
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solution during oxidation were examined in order to determine whether the ions provide a degree 
of protection potentially indicated by the research (Flashner, M., Hollenberg, P.F., & Coon, M.J., 
1972).  
 
Visualization with IAF Labeling: 
 As illustrated in Figure 10, IAF labeling of pyruvate kinase generally decreases as the 
concentration of hypochlorous acid increases from the control of 0 µM to the highest treatment 
group of 250 µM. Because IAF binds only to free thiols, these results imply that increasing 
oxidation decreases the number of free thiols either by oxidizing some of the thiol groups to 
sulfoxides, forming disulfide bonds between some cysteines, or changing the conformation of 
PK such that fewer cysteines are exposed for tagging in the first place. Interestingly, it is possible 
that the PK treated with 50 µM HOCl could have slightly increased IAF labeling when compared 
to 25 µM HOCl but still less than the control. This could be due to a conformational change that 
exposed another cysteine not previously accessible to the fluorescent tag. From this SDS-PAGE, 
it is unclear how thiol availability affects PK activity; however, the image illustrates that HOCl 
oxidizes the protein in a concentration-dependent manner.  
 
Figure 10: Visualization of pyruvate kinase oxidation by varying concentrations of HOCl with IAF 
labeling 
Lane A: Molecular Weight Standard  Lane B: 0 µM HOCl  Lane C: 25 µM HOCl 
Lane D: 50 µM HOCl  Lane E: 100 µM HOCl  Lane F: 250 µM HOCl 
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Effects on Enzymatic Activity: 
 In an effort to understand how HOCl oxidation alters pyruvate kinase, samples of the 
enzyme treated with a final concentration of 0, 25, 50, 100, and 250 µM HOCl were run with the 
activity assay. The results are summarized in Figure 11 below. Low concentrations (0-50 µM 
HOCl) did not affect activity and consistently saw an average percent decrease in NADH 
absorbance of 92% with a range of 87-92%. As the concentration of HOCl increased to 100 µM, 
the oxidative damage started altering activity for an average percent decrease of 75% with values 
ranging from 71-79%. Oxidation with a final concentration of 250 µM HOCl decreased the 
percent change in NADH absorbance to 49% with a range of 45-57%. As the amount of 
oxidation increased, the spread seemed to widen. It is possible that assay could benefit in more 
precise averages from a quenching step added after the ROS reacts with PK. However, the range 
was not so wide as to warrant the additional risk for error inherent in adding further steps to the 
reaction protocol. From the period over 50-250 µM HOCl, the percent decrease in NADH 
absorbance occurred in a linear fashion (R2=0.9881), which correlates with the concentration-
dependence seen from the visualization of HOCl oxidation with IAF labeling. From this data, 
oxidative damage from high concentrations of HOCl clearly inhibits PK activity. 
Hypochlorous acid is not a cysteine-specific oxidant. Because treatment with DTNB 
showed that modifications to PK’s cysteines decreased activity, it is likely that the damage from 
treatment with HOCl is due at least in part to cysteine oxidation. Furthermore, because the 
percent decrease in NADH absorbance (340 nm) is approximately equivalent between 200 µM 
DTNB and 250 µM HOCl, the chances of oxidative damage to other amino acids as the major 
culprit for enzymatic inhibition are low. Therefore, modifications to cysteines are probably the 
leading cause of inhibition to PK following exposure to oxidation by HOCl.  
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Figure 11:Changes in pyruvate kinase activity as the concentration of HOCl increases 
While these results do not definitively illustrate a change in conformation, it is likely that 
there is some change to the shape of the protein as the concentration of the oxidant increases 
since function is dependent on structure. The decrease in enzymatic activity in the presence of 
higher concentrations of HOCl implies the formation of sulfoxides and/or disulfide linkages 
between or within proteins to at least some cysteines. Further research with tryptophan 
fluorescence and circular dichroism spectroscopy is necessary to observe the changes in PK’s 
shape and would add to the current understanding of the effects of oxidative damage. 
 
Ions Effects: 
Due to literature implicating the monovalent and divalent cations necessary for pyruvate 
kinase activity (Mg2+ and K+) in protecting the enzyme from oxidative damage, Stage 1 
oxidation experiments were carried out in phosphate buffer both with and without ions in order 
to visualize any effects and determine the extent of the protection on activity (Flashner, M., 
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Hollenberg, P.F., & Coon, M.J., 1972). Following the buffer solutions used previously in the lab 
for PK oxidation studies, samples with ions were reacted in SPBS (50 mM PB pH 7.4 with 100 
mM KCl and 10 mM MgSO4). Samples without ions were reacted in PBS (100 mM PB pH 7.4). 
A control for the difference in phosphate buffer concentration showed no disparity in IAF 
labeling or enzymatic activity. 
The presence or absence of ions drastically affects labeling with IAF as visualized from 
the SDS-PAGE illustrated in Figure 12. While tagging continued to decrease as the final 
concentration of HOCl increased over 0, 50, 100, and 250 µM regardless of the buffer solution 
used (Lanes A-D: PBS; Lanes E-H: SPBS), ions reduced the number of available thiols, 
presumably by blocking the cysteines from interactions. This finding is important because ions 
are present in normal, cellular conditions, and such stark differences could imply a cellular 
impediment against protein damage and aggregation under oxidative stress that could prolong the 
maintenance of homeostasis as the concentration of an ROS increases. 
 
Figure 12: Visualization of the effect of cations present in solution at various concentrations of HOCl on 
IAF labeling of pyruvate kinase 
Lanes A-D: Reacted in 100 mM PB pH 7.4  
Lanes E-H: Reacted in 50 mM PB pH 7.4 w/ 100 mM KCl + 10 mM MgSO4 
Lane A/E: 0 µM HOCl  Lane B/F: 50 µM HOCl  Lane C/G: 100 µM HOCl  Lane D/H: 250 µM HOCl  
 
Based on the results from IAF labeling with or without ions present for PK oxidation, one 
would assume that the activity saw similar protection; the ions would prevent HOCl from 
interacting with PK’s cysteines and effectually maintain enzymatic function when compared 
with the samples reacted in the absence of ions. Unfortunately, this was not the case. After 
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countless trials, the activity assays did not indicate any change in activity when ions were present 
during oxidation from the data collected without ions. Nonetheless, it is apparent that the ions 
reduce accessibility of cysteines, which could have further implications for PK outside of its 
activity potentially including interactions with other molecules in vivo. 
 
D. Effects of Adenosine Triphosphate on Oxidation: 
In the active site of pyruvate kinase, the phosphate group on PEP is transferred to ADP, 
which produces ATP and pyruvate. The cations in the binding site (Mg2+ and K+) stabilize the 
high-energy intermediate to facilitate this transfer. When the cell has an energetic excess, ATP, 
the molecule that indicates the energy available in the cell, inhibits PK function since there is not 
a need for more energy production at that moment. From the literature, it is likely that there is a 
critical cysteine in the active site that is necessary for function (Anastasious, D., et al., 2011; 
Brown, C.E., Taylor, J.M., & Chan, L., 1985; Flashner, M., Hollenberg, P.F., & Coon, M.J., 
1972; Poole, L.B., 2015). Since activity assays require ADP as a substrate, testing this hypothesis 
required low concentrations of ATP to understand the effects of blocking the active site from the 
full extent of exposure to an oxidant. As an additional step to the Stage 1 PK oxidation step of 
the assay design, PK was incubated with a 75 µM final concentration of ATP for 5 minutes at 
room temperature before the addition of HOCl at various concentrations to bring the sample to 
the 15 µL final volume. These samples were visualized with IAF labeling and analyzed 
catalytically through LDH-coupled assays to understand the enzymatic significance of oxidative 
damage to the active site. 
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Visualization with IAF Labeling: 
Samples both with and without pre-incubation with ATP were tagged with IAF and run 
on the visualized SDS-PAGE in Figure 13 below. The presence of ATP appears to have similar 
yet slightly decreased labeling of cysteines when compared to the corresponding oxidation 
concentrations (0, 50, 100 µM) without exposure to ATP.  This decrease is subtle but of note 
because it indicates that ATP decreases access of other molecules to the active site.  
 
 
Figure 13: The effect of adenosine triphosphate present in solution at various concentrations of HOCl on 
IAF labeling of pyruvate kinase 
Lane A: Molecular Weight Standard  
Lanes B-D: Reacted with 0 µM ATP Lanes E-G: Reacted with 75 µM ATP final concentration 
Lanes B/E: 0 µM HOCl Lanes C/F: 50 µM HOCl Lanes D/G: 100 µM HOCl 
 
Effects on Enzymatic Activity: 
In order to understand the effects ATP on PK oxidation, samples with and without the 75 
µM final concentration of ATP were run on activity assays. Testing showed that this 
concentration of ATP was too low to exhibit inhibitory effects on the enzyme but still high 
enough to bind in some active sites and potentially restrict access of the oxidant to the cysteines 
of interest. As illustrated in Figure 14, the presence of ATP in solution served a protective role 
on the enzymatic function such that the extent of oxidative damage was less when incubated with 
ATP. In fact, the presence of ATP completely maintained function at 100 µM HOCl despite a 
partial loss of catalytic ability for the control.  
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Figure 14: Changes in pyruvate kinase activity as the concentration of HOCl increases in the presence 
or absence of adenosine triphosphate 
 
These results imply that ATP is binding in the active site and blocking oxidation of a 
cysteine that is essential for function. Furthermore, because activity is maintained until 
incubation with higher concentrations of HOCl, it is likely that this cysteine is minimally 
reactive. While there has been much speculation about the location of this less reactive but 
necessary cysteine, incubation with ATP seems to support the idea of this residue in the active 
site. Knowing where the important cysteines in pyruvate kinase can be found can help better 
understand the effects of oxidative damage in vivo. 
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E. Effects of Fructose-1,6-Bisphosphate on Oxidation: 
Fructose-1,6-bisphosphate (FBP) is an allosteric activator of PK that induces the 
catalytically active tetramer. The FBP allosteric site contains positively charged residues (Arg-
516, Arg-498, Lys-433) that coordinate with the negatively charged phosphate groups of the 
molecule, in addition to hydrogen bonds formed between FBP and the protein backbone (Jurica, 
M.S. et al. 1998). It is likely that there is a cysteine in this binding site, and this residue is 
thought to be highly reactive but non-essential (Anastasious, D., et al., 2011; Brown, C.E., 
Taylor, J.M., & Chan, L., 1985; Flashner, M., Hollenberg, P.F., & Coon, M.J., 1972; Poole, L.B., 
2015). In order to show the presence of a cysteine in this binding site and to understand the 
effects of oxidation to this residue, PK was incubated with a low concentration of FBP as an 
additional step before Stage 1 of the activity assay similar to experimentation with ATP. PK was 
exposed to a 75 µM final concentration of FBP for 5 minutes at room temperature before the 
addition of HOCl at various concentrations to bring the sample to the 15 µL final volume. These 
samples were visualized with IAF labeling and analyzed catalytically through LDH-coupled 
assays to understand the enzymatic significance of oxidative damage to the active site. 
 
Visualization with IAF Labeling: 
Samples were incubated with different concentrations of FBP (0, 25, 50, 100, 150, 330 
µM) before tagging with IAF and analyzing on an SDS-PAGE as shown in Figure 15 courtesy of 
M.C. Duff, another researcher in Dr. Landino’s laboratory. As the concentration of FBP 
increases, the extent of labeling decreased. This finding is interesting because it implies the 
presence of a cysteine in the FBP allosteric site such that increasing the concentration of the 
regulatory molecule increases the frequency of binding in the site, which decreases access to the 
residue. It is unclear whether this decreased access is due specifically to FBP binding in the 
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allosteric site or whether merely an increased presence of molecules in solution obstructs the 
path of the fluorescent tag, a similar concern with ATP incubation. Fortunately, the 
corresponding activity assays provided some insight to the potential issue. 
 
Figure 15: The effect of various final concentrations of fructose-1,6-bisphosphate present in solution on 
IAF labeling of pyruvate kinase 
Lane A: 0 µM Lane B: 25 µM Lane C: 50 µM Lane D: 100 µM Lane E: 150 µM Lane F: 330 µM 
Figure courtesy of Duff, M.C. & Landino, L.M. (2017). 
 
Effects on Enzymatic Activity: 
 PK incubated with 75 µL FBP before exposure to either 0 or 250 µM HOCl did not see 
any difference in activity levels as measured through percent change in NADH absorbance at 
340 nm, which indicates that the cysteine in the allosteric site is not critical for enzymatic 
function. The results of these assays are important for two main reasons. First, it illustrates an 
important control: that the mere presence of molecules in solution is not enough to impede 
oxidation but rather that FBP and ATP were most likely binding in their respective binding sites 
throughout the incubation experiments. Secondly, it confirms that the cysteine in the FBP 
binding site is likely to be the highly reactive but non-essential thiol, which is vital for 
understanding how the protein works and the impacts oxidative damage could have in vivo. 
PART IV: CONCLUSIONS: 
 Overall, this research gave new insight into the effects of oxidative damage to pyruvate 
kinase and the location of key cysteines in each PK subunit through visualization of IAF labeling 
by SDS-PAGE and the development of a LDH-coupled activity assay.   
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One of the major accomplishments of this research was the protocol to analyze PK 
function. By measuring the percent change in NADH absorbance at 340 nm, it was possible to 
determine the degree of PK catalytic activity quantitatively in response to various experimental 
conditions. The protocol relied on a three-step design: 1) PK modification, 2) PK catalysis, and 
3) LDH catalysis. By dividing the assay into these stages, it was possible to establish more 
controls for more accurate results. After the protocol demonstrated its consistency and reliability, 
analysis of PK functionality expanded to understand the effects of oxidation.  
 Using the activity assay protocol, it was possible to understand the broader extent of 
oxidative stress on PK. Non-specific oxidation of PK by hypochlorous acid (HOCl) likely affects 
cysteines as illustrated through IAF labeling and comparisons with modification of thiol groups 
by Ellman’s Reagent (DTNB), a thiol-specific reagent. Oxidative damage to PK causes a partial 
loss of function observable at cysteine:oxidant ratios at or exceeding 1:40. Inhibition to PK as a 
result of oxidation increases as the concentration of HOCl increases. Interestingly, the presence 
of cations (Mg2+ and K+) in solution increases the frequency of modification by DTNB with 
corresponding decreased activity. Ions present in solution for HOCl oxidation, on the other hand, 
dramatically decreased IAF labeling but did not appear to affect catalytic function as indicated 
by the LDH-coupled activity assays. These results expand the knowledge of PK thiol reactivity 
and enzymatic ability.  
Additionally, the assay facilitated a better understanding of enzymatic structure and the 
location of key cysteines that are important for cellular function. By incubating PK with a low 
concentration of ATP before adding the oxidant, it was possible to observe the changes to IAF 
labeling and enzymatic function. Based on the results, there is likely a cysteine in the active site, 
where ATP binds, that is critical for function. When ATP was present in solution, there was 
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decreased access to the cysteine in the binding site, which maintained enzymatic function at 
higher levels of oxidation and decreased IAF labeling. Based on the research, it is likely that the 
cysteine in the active site is the minimally reactive but highly essential cysteine, which 
corresponds with predictions from the literature (Anastasious, D., et al., 2011; Brown, C.E., 
Taylor, J.M., & Chan, L., 1985; Flashner, M., Hollenberg, P.F., & Coon, M.J., 1972; Poole, L.B., 
2015). Similarly, incubation with a low concentration of fructose-1,6-bisphosphate before 
treatment with HOCl illustrates that there is likely a cysteine in the FBP allosteric site as 
indicated by the decrease in IAF labeling. The presence of FBP in solution, however, did not 
affect activity in response to oxidative stress, which indicates that this cysteine is likely the 
highly reactive but non-essential cysteine discussed in the literature (Anastasious, D., et al., 
2011; Brown, C.E., Taylor, J.M., & Chan, L., 1985; Flashner, M., Hollenberg, P.F., & Coon, 
M.J., 1972; Poole, L.B., 2015). The data from this research confirms speculation of key cysteines 
in addition to giving insight to PK structure and function. 
 From this data, there are numerous avenues for immediate further research. It may be 
possible that the loss of PK activity after treatment with an oxidant can be restored when treated 
with a reducing agent. Therefore, further research is necessary to understand the extent to which 
PK can be modulated to restore catalytic function. It may be that low levels of oxidative stress in 
vivo can occur without severe consequences to cellular metabolism since intracellular conditions 
favor reduced molecules. On the other hand, because it takes a ratio of cysteine:oxidant greater 
than 1:40 to see a decrease in enzymatic function, the amount of reducing agent necessary to 
undo oxidative damage, if this reverse is even possible, may exceed reasonable physiologically 
relevant concentrations. Another potential route for future research on PK oxidation studies is 
conformational changes in response to treatment with an ROS. While the results of the project 
 40 
imply a change in protein shape based on the impaired function, more definitive methods of 
observation should be applied in order fully to understand the effects of oxidative damage on PK. 
Analysis of the effects of PK oxidation on tryptophan fluorescence and circular dichroism 
spectroscopy would aid in understanding conformational changes that may occur as the thiol 
groups are oxidized to form sulfoxides and/or disulfide linkages that could have distorted the 
overall structure. The data collected for this project adds to the overall picture of PK oxidation, 
but there is still more to explore.  
Taken together, this research provides more insight into the role of PK under oxidative 
stress, as well as a protocol for further research on the topic. It may be possible that PK can 
modulate function under low levels of oxidation through the modification of the cysteines’ thiol 
groups.  This modulation could serve a protective role in vivo to maintain metabolic and 
cytoskeletal function through interactions with other glycolytic enzymes and tubulin. If possible, 
this defense mechanism could potentially prevent the onset of some neurodegenerative 
symptoms, such as those characteristic of Alzheimer’s disease. 
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Part V: APPENDIX: 
A. Tables of Abbreviations and Chemical Index: 
Enzymes Abbreviation 
Pyruvate kinase PK 
Lactate dehydrogenase LDH 
 
 
Buffer Solutions Abbreviation 
50 mM Phosphate buffer pH 7.4 PBS 
50 mM Phosphate buffer pH 7.4 with 100 mM KCl and 10 mM MgSO4 SPBS 
50 mM Tris buffer with of 100 mM KCl and 10 mM MgSO4 STris 
 
 
Molecules Structures Abbreviations 
Phosphoenolpyruvate 
 
PEP 
Adenosine diphosphate 
 
ADP 
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Adenosine triphosphate 
 
ATP 
Fructose-1,6-bisphosphate 
 
FBP 
Nicotinamide adenine dinucleotide 
 
NADH 
Ellman’s Reagent: 5,5-dithio-bis-[2-
nitrobenzoic acid]) 
 
DTNB 
Hypochlorous Acid 
 
HOCl 
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5-iodoacetamidofluorescein 
 
IAF 
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